Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Researchers can request the full batch file (CoA, originating lab name, fill date) by quoting the batch number to our support desk
May 5, 2026 GHK-Cu is available in cosmetic skincare formulations over the counter and through Research Use Only research peptide suppliers
The practical result, in our clinical experience, is that patients with a subacute tendinopathy that has stalled at 6 to 12 weeks of physical therapy tend to notice a meaningful change in pain level and range of motion within 3 to 4 weeks of starting a BPC-157 protocol
The regulatory framework isnt designed to chase down thousands of small international shipments stamped for lab use
Daily Protocol: 1 to 2 mg subcutaneous injection once daily Alternate Protocol: 2 to 3 mg subcutaneous injection three times weekly Cycle Length: 8 to 12 weeks on Rest Period: 4 to 6 weeks off between cycles Cycles Per Year: 2 to 3 cycles recommended Injection Sites: Abdomen, outer thigh, or upper arm with rotation Cycling Recommendations Research suggests running GHK-Cu in cycles of 8 to 12 weeks followed by rest periods of 4 to 6 weeks
